Tyfoxylou, E.; Voulgaris, N.; Gravvanis, C.; Vlachou, S.; Markou, A.; Papanastasiou, L.; Tentolouris, N.; Kassi, E.; Kaltsas, G.; Chrousos, G.P.;
et al. High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension. Biomedicines 2022, 10, 2308.
https://doi.org/10.3390/biomedicines10092308
AMA Style
Tyfoxylou E, Voulgaris N, Gravvanis C, Vlachou S, Markou A, Papanastasiou L, Tentolouris N, Kassi E, Kaltsas G, Chrousos GP,
et al. High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension. Biomedicines. 2022; 10(9):2308.
https://doi.org/10.3390/biomedicines10092308
Chicago/Turabian Style
Tyfoxylou, Ernestini, Nick Voulgaris, Chris Gravvanis, Sophia Vlachou, Athina Markou, Labrini Papanastasiou, Nikolaos Tentolouris, Eva Kassi, Gregory Kaltsas, George P. Chrousos,
and et al. 2022. "High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension" Biomedicines 10, no. 9: 2308.
https://doi.org/10.3390/biomedicines10092308
APA Style
Tyfoxylou, E., Voulgaris, N., Gravvanis, C., Vlachou, S., Markou, A., Papanastasiou, L., Tentolouris, N., Kassi, E., Kaltsas, G., Chrousos, G. P., & Piaditis, G. P.
(2022). High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension. Biomedicines, 10(9), 2308.
https://doi.org/10.3390/biomedicines10092308
